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Abstract
Even though highly vascularized, the
thyroid gland rarely has spontaneous
bleeding. Bleeding into the thyroid gland
can result in potentially lethal acute airway
compromise. This case report describes an
elderly patient on warfarin for atrial fibril-
lation, who presented with swelling on the
right side of her neck causing acute airway
obstruction. An urgent computed tomogra-
phy of the neck showed an enlarging hem-
orrhage into the right lobe of the thyroid
gland. She was initially intubated for air-
way protection and her anticoagulation
was reversed to stop the bleeding. She was
closely monitored in the intensive care
unit. After an uncomplicated tracheal extu-
bation and recovery, she was discharged
and scheduled for an elective total thy-
roidectomy. We desire that physicians be
aware of this rare, potentially lethal bleed-
ing complication.
Introduction
The thyroid gland is a highly vascular-
ized organ; however, spontaneous bleeding
into the gland is rare and only a few cases
have been reported.1-7 Bleeding into this
area can lead to sudden, life-threatening
airway compromise by tracheal compres-
sion. Preexisting benign conditions such as
a goiter, nodule, and cyst can increase the
vascularity of the gland and may increase
the vulnerability for bleeding.1
Anticoagulation treatment may potentiate
the severity of spontaneous bleeding,
including bleeding into a goiter. We
describe a rare cause of acute airway
obstruction secondary to spontaneous thy-
roid hemorrhage in the context of antico-
agulant therapy with warfarin.
Case Report
A 91-year-old female presented to the
emergency department with progressively
worsening dyspnea that began a few hours
prior to presentation. Her pertinent medical
history was significant for hypertension,
atrial fibrillation on anticoagulation with
warfarin, and hyperthyroidism due to
Graves’ disease in the setting of multinodu-
lar goiter. The patient had been well con-
trolled on warfarin therapy, with no recent
international normalized ratio (INR) excur-
sions, with a longitudinal time-in-therapeu-
tic range of 89%. Other chronic medications
included atenolol, furosemide, and methi-
mazole. The patient described her dyspnea
as trouble getting air though [her] throat
that was present even at rest. She also
noticed a red-colored, pea-sized swelling in
the right side of the neck, which had been
enlarging with increasing tenderness. She
had hoarseness of voice, but was able to
phonate well. The patient was initially able
to swallow liquids at the onset of symp-
toms, but progressively had difficulty in the
hours that followed. The patient denied any
trauma or ingestion of foreign objects. She
had been on anticoagulation for 4 years,
without any history of provoked or sponta-
neous bleeding complications.
Examination revealed an elderly
woman in mild distress. Vital signs included
a blood pressure of 130/96 mm Hg, normal
temperature, an irregular heart rate of
around 100 beats/minute, and a respiratory
rate of 20 breaths/minute. Oxygen satura-
tion was 99% on 2 L of oxygen. She had an
irregularly enlarged thyroid with a 5×4 cm
area of ecchymosis on the right side that
was tender to the touch. She did not have
labored breathing or stridor. She did have
bilateral basal crackles on chest ausculta-
tion, with systolic ejection murmur in the
aortic area. 
Initial laboratory studies showed an
INR of 2.0 (therapeutic goal 2.0-3.0), a thy-
roid stimulating hormone of 1.68 mIU/L
(normal range 0.34-3.00 mIU/L), and a
hemoglobin of 12.5 g/dL (normal range
11.5-15.5 g/dL). Chest x-ray showed car-
diomegaly with mild pulmonary vascular
prominence. In view of the worsening respi-
ratory distress, urgent computed tomogra-
phy of the neck was done, which showed an
enlarged, heterogeneous thyroid gland, with
a large (5.7×5.2×4.9 cm) heterogeneous
nodule in the inferior right thyroid lobe con-
sistent with an active intrathyroidal hemor-
rhage (Figure 1). The hemorrhage was caus-
ing mild mass effect on the subglottic tra-
chea with substernal extension into the
upper mediastinum. No bleeding into the
retropharyngeal or parapharyngeal space
was seen.
Based on the clinical and radiologic
findings, the diagnosis of thyroid hemor-
rhage was made. As the patient was at risk
for airway compromise in the setting of
apparent expanding thyroid goiter hemor-
rhage, she was intubated and mechanically
ventilated in the intensive care unit. She
received 10 mg of intravenous vitamin K
for reversal of anticoagulation, along with 3
units of fresh frozen plasma, and the INR
was 1.3 within 6 hours later. The hemoglo-
bin decreased to 11.3 g/dL and the hemat-
ocrit to 33.9% within 12 hours of the initial
values, then remained stable. No further
blood product transfusion was required.
Warfarin was held through admission.
In the subsequent days, the ecchymosis
started to decrease in size and the thyroid
gland became softer. The patient tolerated
extubation on day 5 of hospitalization,
although severe residual oropharyngeal
dysphagia and speech and swallowing diffi-
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culties continued. The patient was subse-
quently discharged to a rehabilitation facili-
ty on day 17 of her hospitalization and was
scheduled for elective outpatient thyroidec-
tomy. 
Discussion
Thyroid hemorrhage has been rarely
reported even though the gland is highly
vascularized. The common causes include
fine needle aspiration, trauma, and sponta-
neous bleeding occurring with or without
the concurrent use of anticoagulants.1
Preexisting conditions such as a goiter, cyst,
and nodule increase the risk of bleeding into
the thyroid. Two proposed mechanisms
might lead to hemorrhage into a goiter:
abnormal thyroid vascular anatomy, and
arteriovenous shunting in a cyst or nodule.
Strenuous activity can increase the venous
pressure and cause rupture of the vessels
resulting in a thyroid hematoma.8,9
In the United States, the most common
causes of goiter in the elderly are Graves’
disease and multinodular goiters.10 In this
elderly patient population, atrial fibrillation
is a common arrhythmia, encountered in
10%-15%.11 Chronic anticoagulation, with
warfarin or direct-acting oral anticoagu-
lants, is indicated in patients with atrial fib-
rillation to prevent embolic strokes.12,13
Administration of anticoagulants is often
associated with the risk of bleeding. Trials
across all anticoagulants (apixaban, dabiga-
tran, edoxaban, rivaroxban, and warfarin)
have been done to evaluate the bleeding
complications due to the treatment; howev-
er, none revealed any spontaneous thyroid
hemorrhage.14-18 Given the high incidence
of atrial fibrillation in the elderly popula-
tion, the potential exists for large numbers
of patients with a goiter and other thyroid
abnormalities to be on anticoagulation ther-
apy. Only 2 cases of spontaneous thyroid
hemorrhage have been reported in patients
on anticoagulation for atrial fibrillation.1,3
Similar to our case, both of these cases
occurred spontaneously in elderly women
(ages 72 and 73 years), who were within
therapeutic range on warfarin therapy, with
INRs between 2.0 and 3.0 (2.1 and 3.0).1,3
The literature is also limited with few
reports of spontaneous thyroid hemorrhage
in the presence of other anticoagulants for
other indications. These reports include
warfarin for mechanical valve replacement
at a supratherapeutic INR of 12.8,2 intra-
venous recombinant tissue plasminogen
activator for an acute cerebral vascular acci-
dent,6 combination clopidogrel/
aspirin/enoxparin (indication not stated),7
therapeutic low-molecular weight heparin
therapy for treatment of deep vein thrombo-
sis,5 and aspirin monotherapy (indication
unknown).4 As seen in our patient, acute
hemorrhage within a goiter may compress
the trachea and cause acute airway obstruc-
tion. The airway should be secured first
with endotracheal intubation before any
complex diagnostic and treatment proce-
dures.19 Bleeding into the thyroid gland is
best diagnosed with computed tomography.
If the patient is on warfarin or other antico-
agulants, the anticoagulation should be
reversed immediately, if possible, to stop
further bleeding and airway compromise.
Early surgical decompression is indicated
only if the patient continues to have bleed-
ing or mediastinal extension. Management
may include partial or total thyroidectomy
as well as further treatment with thyroid
hormones to prevent hypothyroidism.4
Additionally, hemorrhage into the thyroid
gland can result in release of preformed thy-
roid hormones and can cause acute hyper-
thyroidism. However, this is usually self-
limiting and does not warrant any
treatment.5,20
Conclusions
With an increase in the number of
patients receiving anticoagulation therapy,
physicians should be aware of this rare, life-
threatening, thyroid bleeding complication
particularly in patients with goiters,
enabling prompt recognition and manage-
ment of these conditions.
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